Market Overview / Summary The global non-small cell lung cancer market size was valued at USD 34.14 billion in 2024, growing at a CAGR of 14.3% from 2025–2034. Rising global incidence of non-small cell lung cancer (NSCLC), coupled with growing adoption of liquid biopsies and multiplexed platforms is enabling non-invasive monitoring in NSCLC. The adoption of next-generation diagnostics,...